NCT07035665

A Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects

A Single-Center, Randomized, Open-Label, Crossover Clinical Study to Evaluate the Effect of Food on the Pharmacokinetic Profiles of HRS-5965 Capsules in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Chengdu Suncadia Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The study is being conducted to evaluate the effect of food on pharmacokinetics of HRS-5965 capsules after oral administration.

Conditions

• IgA Nephropathy
• Paroxysmal Nocturnal Hemoglobinuria

Interventions

Type	Name	Description
DRUG	HRS-5965 Capsules	Oral doses of HRS-5965 capsules at fasted and fed conditions.

Timeline

• Start date: 2025-06-30
• Primary completion: 2025-07-22
• Completion: 2025-07-22
• First posted: 2025-06-25
• Last updated: 2025-08-20

Locations

1 site across 1 country: China